Study of Anti-CD33 Chimeric Antigen Receptor-Expressing T Cells (CD33CART) in Children and Young Adults With Relapsed/Refractory Acute Myeloid Leukemia
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03971799 |
|
Recruitment Status :
Recruiting
First Posted : June 3, 2019
Last Update Posted : May 14, 2024
|
Sponsor:
Center for International Blood and Marrow Transplant Research
Collaborators:
National Marrow Donor Program
St. Baldrick's Foundation
Information provided by (Responsible Party):
Center for International Blood and Marrow Transplant Research
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | December 2029 |
| Estimated Study Completion Date : | December 2039 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):